EP4472600A1 - Closing element for pharmaceutical containers and process for producing such closing element - Google Patents

Closing element for pharmaceutical containers and process for producing such closing element

Info

Publication number
EP4472600A1
EP4472600A1 EP23707791.2A EP23707791A EP4472600A1 EP 4472600 A1 EP4472600 A1 EP 4472600A1 EP 23707791 A EP23707791 A EP 23707791A EP 4472600 A1 EP4472600 A1 EP 4472600A1
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical container
closing element
pharmaceutical
aperture
seal portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23707791.2A
Other languages
German (de)
French (fr)
Inventor
Mario BARTOLOMEI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metalco Srl
Original Assignee
Metalco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metalco Srl filed Critical Metalco Srl
Publication of EP4472600A1 publication Critical patent/EP4472600A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A61J1/1425—Snap-fit type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/14—Rigid discs or spherical members adapted to be held in sealing engagement with mouth of container, e.g. closure plates for preserving jars
    • B65D51/145—Rigid discs or spherical members adapted to be held in sealing engagement with mouth of container, e.g. closure plates for preserving jars by means of an additional element connected directly to the container
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/18—Arrangements of closures with protective outer cap-like covers or of two or more co-operating closures

Definitions

  • the present invention relates to the pharmaceutical field and it relates , precisely, to a closing element , in particular a closure , or lid, or any other similar element for sealing a container such as a bottle , a vial , a small bottle , etc . that is intended to contain a pharmaceutical product .
  • the invention relates to a process for producing such a closing element for pharmaceutical containers .
  • closures that must be able to guarantee the integrity and the inviolability of their content until they are opened by the authori zed person .
  • a very widespread type of closures for pharmaceutical containers comprises two distinct parts . More precisely, these closures provide a first part , normally a lid made of vulcani zed rubber, provided with a portion that , in working conditions , is housed within the container, and with another portion that , in use , is positioned in contact with the edge of the mouth of the pharmaceutical container .
  • the closing element furthermore , comprises a second part made of a metallic material , generally aluminium, which is superimposed to the aforementioned first part and fixed to the container, for example by crimping, in such a way that once removed it cannot be used anymore .
  • the second part of the closing element has , on the one hand, the aim to push the first part against the mouth of the pharmaceutical container in order to hermetically close the same and, on the other hand, it has the function of a seal , because it guarantees that it is not possible to reach the first part of the closing element without leaving any mark of the removal of the second part and, therefore , it guarantees the inviolability of the content of the pharmaceutical container .
  • the aforementioned type of closing members for pharmaceutical containers has a not-negligible environmental impact in particular due to the high quantity of vulcani zed rubber that is needed .
  • a further disadvantage of the closures for pharmaceutical containers formed by more components is that , at the moment to draw up the inventory, each component has to be registered separately with great loss of time and complications .
  • closures described in these documents are of the type that can be pierced by a needle to draw its content by a syringe . More in detail , the closures that are described in these documents are provided with a removable portion in order to expose , once removed, a portion made of rubber, or other material , suitable to be pierced by the needle . Therefore , these closures can be used only in the case that the pharmaceutical product contained within the pharmaceutical container is in liquid form and intended to be administered to the patient by inj ection .
  • an obj ect of the present invention to provide a closing element for pharmaceutical containers that is able to overcome the drawbacks above disclosed of the closing members of prior art . It is , in particular, an obj ect of the present invention to provide a closing element for pharmaceutical containers that is able to simpli fy the processes for sterili zing the pharmaceutical containers and, therefore , to speed up the same in addition to reduce costs with respect to the closing members of prior art .
  • a closing element for a pharmaceutical container provided with a cavity delimited by a lateral wall and with an aperture through which it is possible to reach said cavity, said aperture being laterally delimited by an edge , said closing element having a main body comprising :
  • seal portion configured to be engaged to said pharmaceutical container, said seal portion being provided with a weakening line delimiting a first part and a second part of said seal portion, said second part being arranged to be removed disengaging the same from said first part at said weakening line ;
  • a sealing portion made of elastic material and configured to be housed, in use , within said housing portion and to be positioned in contact with said edge of said aperture ; whose main characteristic is that the aforementioned housing portion and the aforementioned sealing portion are firmly anchored to each other at respective engagement surfaces , in such a way to be removed integrally with each other from the pharmaceutical container, that said seal portion is arranged to be engaged to said pharmaceutical container at said second part and that the weakening line is positioned, in use , below the aforementioned edge , in such a way that when said second part of said seal portion is removed, the sealing element is still covered by the first part of the seal portion .
  • the aforementioned housing portion faces , in use , towards the aforementioned edge of the aforementioned aperture .
  • the housing portion and the sealing portion can be firmly anchored to each other at the aforementioned engagement surface by an inj ection moulding process .
  • the housing portion and the sealing portion can be firmly anchored to each other at the aforementioned engagement surface by a process di comoulding, in particular co-moulding of metal and plastic materials .
  • the aforementioned main body can be made of a metallic material . More in particular, the main body can be made of aluminium . In this way, it is possible , in particular, to simpli fy the process for sterili zing the pharmaceutical container .
  • the aforementioned sealing portion can be made of rubber .
  • the aforementioned weakening line can be configured in such a way to disengage , in particular in an irreversible way, the aforementioned second part from the aforementioned first part of the seal portion when the second part is caused to rotate tangentially to the aforementioned first part .
  • the second part of the seal portion can be provided with a grasp portion configured to be grasped by a user in order to pull the second part same , in particular causing it to rotate tangentially to the aforementioned first part as above disclosed, in such a way to separate it from the first part .
  • the aforementioned sealing portion can be provided with at least one through hole adapted to be positioned, in use , above the aforementioned aperture of the pharmaceutical container .
  • the aforementioned sealing portion can have an annular shape .
  • the aforementioned sealing portion can be a substantially flat shaped element .
  • the sealing portion can have a circular, or elliptical , or polygonal , for example rectangular, or square, cross section .
  • a process for producing a closing element for a pharmaceutical container provided with a cavity laterally delimited by a lateral wall and with an aperture through which it is possible to reach the aforementioned cavity, said aperture being laterally delimited by an edge , said process comprising the steps of :
  • a process for producing a closing element for a pharmaceutical container provided with a cavity laterally delimited by a lateral wall and with an aperture through which it is possible to reach the aforementioned cavity, said aperture being laterally delimited by an edge , said process comprising the steps of :
  • main body in particular made of metallic material , within a mould, said main body being provided with :
  • a seal portion configured to be engaged, in use , to said pharmaceutical container, said seal portion being provided with a weakening line delimiting a first part and a second part of said seal portion, said seal portion being arranged to be engaged to said pharmaceutical container at said second part , said second part being arranged to be removed disengaging form said first part at said weakening line , said weakening line being positioned, in use , below said edge of said pharmaceutical container ;
  • a system for storing a product in particular a pharmaceutical product, comprises:
  • a pharmaceutical container provided with a cavity delimited by a lateral wall and with an aperture through which it is possible to reach said cavity, said aperture being laterally delimited by an edge ;
  • the pharmaceutical container in particular made of metallic material , such as aluminium, or an aluminium alloy, can be provided with an end portion which protrudes from the aforementioned edge . More in particular, the aforementioned end portion can be configured to protrude from the aforementioned edge up to a free end .
  • the aforementioned end portion can be shaped in such a way to bend towards the pharmaceutical container, in particular towards a portion having a reduced cross section, or neck, of the pharmaceutical container same .
  • the free end of the end portion can be , in particular, positioned at a predetermined distance d from the lateral wall , in particular from the aforementioned portion having a reduced cross section, or neck of the pharmaceutical container .
  • the aforementioned seal portion can be arranged to be engaged, in particular by crimping, to the pharmaceutical container at the aforementioned free end of the end portion .
  • the main body of the closing element and the pharmaceutical container can be made of the same material or, however, of two materials that can be sterili zed, in particular two metallic materials that can be sterili zed, for example aluminium, or an aluminium alloy .
  • Fig . l diagrammatically shows a side elevation perspective view of a pharmaceutical container provided with a closing element according to the invention in a disassembled configuration
  • Fig . 2 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 1 in an assembled configuration
  • Fig . 3 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element of figure 2 ;
  • Fig . 4 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 3 to highlight some technical aspects
  • Fig . 5 diagrammatically shows a side elevation perspective view of a pharmaceutical container provided with an embodiment of the closing element alternative to that one of figure 2 ;
  • Fig . 6 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 5 during an initial stage of the removal step of the seal portion;
  • Fig . 7 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element of figure 6 ;
  • Fig . 8 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 7 to highlight some technical aspects ;
  • Fig . 9 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 5 at the end stage of the removal step of the seal portion;
  • Fig . 10 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element of figure 9 ;
  • Fig . 11 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 10 to highlight some technical aspects ;
  • Fig . 12 diagrammatically shows a side elevation perspective view of a pharmaceutical container provided with a further embodiment of the closing element alternative to that of figure 2 ;
  • Fig . 13 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 12 during an initial stage of the removal step of the seal portion;
  • Fig . 14 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element di figure 12 ;
  • Fig . 15 diagrammatically shows a longitudinal cross section view of a pharmaceutical container provided with still another alternative embodiment of the closing element according to the invention.
  • Fig . 16 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 15 to highlight some technical aspects ;
  • Fig . 17 diagrammatically shows a perspective view of a possible alternative embodiment of the sealing element that can be used for the closing element according to the invention
  • Fig . 18 diagrammatically shows a longitudinal cross section view of a possible embodiment alternative to that one of figure 16 of a pharmaceutical container to which the closing element according to the invention can be applied;
  • Fig . 19 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 18 to highlight some technical aspects ;
  • Fig . 20 diagrammatically shows a longitudinal cross section view of a possible embodiment alternative to that one of figure 19 of the closing element according to the invention
  • Fig . 21 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 20 to highlight some technical aspects ;
  • Fig . 22 diagrammatically shows a block diagram of the main steps of the process , according to the invention, for producing the closing element for pharmaceutical containers ;
  • Fig . 23 diagrammatically shows a block diagram of the main steps of another process , according to the invention, for producing the closing element for pharmaceutical containers ;
  • Fig . 24 diagrammatically shows a possible layout of a plant for producing the closing element for pharmaceutical containers according to the invention .
  • a closing element 1 for a pharmaceutical container 50 , such as a bottle , a vessel , a small bottle , a flask, provided with a cavity 55 delimited by a lateral wall 51 and an aperture 52 laterally delimited by an edge 53 , through which it is possible to reach the aforementioned cavity 55 .
  • the closing element 1 comprises , in particular, a main body 10 comprising a seal portion 15 configured to be engaged to the lateral wall 51 of the pharmaceutical container 50 , for example by crimping .
  • the aperture 52 of the aforementioned pharmaceutical container 50 can have a diameter equal to , or greater than 20 mm, for example comprised between 20 mm and 220 mm .
  • the closing element 1 comprises , furthermore , a housing portion 11 , in particular facing, in use , towards the aforementioned edge 53 of the aperture 52 , and a sealing portion 20 made of an elastic material and configured to be housed, in use , within the housing portion 11 . More in particular, the sealing portion 20 i s adapted to be positioned, in use , in contact with the edge 53 of the aperture 52 in such a way to tightly close the pharmaceutical container 50 .
  • the main body 10 and the aforementioned sealing portion 20 which is housed within the housing portion 11 , are firmly anchored to each other at respective engagement surfaces 16 and 26 by an inj ection moulding, or co-moulding, process , in particular a co-moulding process of metal and plastic materials .
  • the main body 10 can be made of a metallic material , preferably aluminium, or an aluminium alloy .
  • the aforementioned sealing portion 20 can be made of rubber, preferably butyl rubber .
  • the seal portion 15 comprises a first part 15a and a second part 15b mutually engaged to each other in a removable way at an engagement portion 19 . More precisely, the seal portion 15 is engaged to the pharmaceutical container 50 , in particular to the neck of this , at the second part 15b .
  • the seal portion 15 is provided with a weakening line 18 , in particular a portion having a reduced thickness , or a pre-cut line .
  • the weakening line 18 delimits the first and the second part 15a and 15b, in the sense that it indicates the limit between the first and the second part 15a and 15b, of the seal portion 15 .
  • the closing element 1 is disengaged from the pharmaceutical container 50 and can be removed from the closing position of the aperture 52 when desired .
  • the weakening line 18 and therefore the engagement portion 19 , can be configured in such a way to be broken disengaging the second part 15b of the seal portion 15 from the first part 15a, when a rotation of the second part 15b tangentially to the first part 15a is caused .
  • the weakening line 18 can be obtained by reducing locally the thickness of the seal portion 15 , whereby when the user grasps the second part 15b and applies a determined force on the same , it causes it to be separated from the first part 15a at the weakening line 18 .
  • the removal of the second part 15b that means the breaking of the engagement portion 19
  • the removal of the second part 15b can be obtained by rotating the second part 15b with respect to the first part 15a, in such a way to cause the two parts 15a and 15b of the seal portion 15 to be separated from each other .
  • the technical solution provided by the present invention allows to avoid that , during the removal of the seal portion 15 , some particles of the material of which it is made of , can enter the pharmaceutical container 50 contaminating its content .
  • the seal portion 15 can be configured in such a way that once that the second part 15b is removed, the sealing element 20 is not exposed, and, therefore , it cannot be reached from the outside . This can be obtained, in particular, by positioning the weakening line 18 in a position such that when the second part 15b of the seal portion 15 is removed, the sealing element 20 remains covered, that means hidden, by the first part 15b, in particular entirely covered by the first part 15b .
  • the weakening line 18 can be made in such a way to be positioned, in use , below the edge 53 , or at least at the same height . In this way, at the moment to remove the second part 15b of the seal portion 15 , it is guaranteed that the sealing element 20 remains in a correct working position avoiding that extraneous bodies , in particular dust , dirty, which settles on the lateral wall 51 of the pharmaceutical container 50 , or on the seal portion 15 same , as well as other impurities , in particular metallic fragments of the material of which the pharmaceutical container 50 , and/or the closing element 1 , is made of , can enter the cavity 55 , contaminating its content .
  • the aforementioned pharmaceutical container 50 can be provided with an end portion 56 which protrudes from the edge 53 .
  • the aforementioned end portion 56 starting from the aforementioned edge 53 from which it protrudes , bends towards the pharmaceutical container 50 , in such a way to be superimposed on a part of the lateral wall 51 of the pharmaceutical container 50 , in particular at least on a part of a portion having a reduced cross section, or neck 57 , of which the container same is provided of . More precisely, the end portion 56 protrudes from the edge 53 up to a free end 59 .
  • Thi s is , preferably, positioned at a predetermined distance d from the lateral wall 51 of the pharmaceutical container, in particular the neck 57 of the same , i f present .
  • the end portion 56 together with the pharmaceutical container 50 can delimit a cavity 58 .
  • the weakening line 18 can be configured in such a way to be positioned, in use , at the end portion 56 , in particular between the edge 53 and the free end 59 of the end portion 56 .
  • the seal portion 15 can be engaged, for example by crimping, to the free end 59 of the end portion 56 , in such a way to ensure a firm anchoring of the seal portion 15 , and precisely of the second part 15b of this , to the pharmaceutical container 50 .
  • the second part 15b of the seal portion 15 can be provided with a grasp portion 17 configured to be grasped by a user in order to cause the same to be rotated tangentially to the first part 15a, as disclosed above .
  • the grasp portion 17 can extend along a direction that is substantially radial to the main body 10 of the closing element 1 ( case that is shown in the figures from 5 to 11 ) or along a direction that is substantially tangential to the main body 10 (case that is shown as an example in the figures from 12 to 15 ) .
  • the sealing element 20 can extend between the opposite end portions 54a and 54b of the edge 53 of aperture 52 of the pharmaceutical container 50 and, therefore , be positioned upon the aperture 52 same for al l its length ( case that is shown, for example , in the figures 10 and 14 ) .
  • the sealing element 20 can have a substantially flat shape .
  • the sealing element 20 can be provided with at least a hole 22 superimposed, in use , to the aperture 52 of the pharmaceutical container 50 .
  • the sealing element 20 can have an annular, or substantially annular, shape , in particular with a polygonal cross section, advantageously substantially square , or rectangular, or curved, in particular substantially elliptical , or circular, and can be placed on the edge 53 of the aperture 52 , but not upon this latter, or however, not upon the whole aperture 52 , leaving at least a part of the aperture 52 uncovered .
  • the sealing element is shown having a circular cross section, it is not excluded that it can have an elliptical , or polygonal , in particular square , or rectangular, cross section, cases that are not shown in the figure .
  • the main body 10 of the closing element 1 and the pharmaceutical container 50 are made of the same material , advantageously aluminium, or an aluminium alloy .
  • the necessary sterile conditions for the product that is contained in it are , anyway, maintained, thus avoiding any contamination of the same and, therefore , assuring the absolute integrity of the same .
  • a pharmaceutical container 50 and a closing element 1 as described above with reference to the figures from 1 to 20 form a system 100 for storing a pharmaceutical product .
  • a process for producing a closing element 1 for a pharmaceutical container 50 such as a bottle , a small bottle , a test tube , but also a vial , and similar containers that are used in the pharmaceutical field, of the type described above with reference to the figures from 1 to 16 , and, in particular, provided with a cavity
  • the process provides a step of disposing of a main body 10 provided with a seal portion 15 configured to be engaged, in use , to the lateral wall 51 of the pharmaceutical container 50 and with a housing portion 11 , in particular adapted to face , in use , towards the edge 53 of the aperture 52 , block 301 .
  • a step is provided of positioning a sealing portion made of elastic material within the aforementioned housing portion 11 , block 302 , and therefore , a step for anchoring the housing portion 11 and the sealing portion 20 to each other at respective engagement surfaces 16 and 26 , block 303 .
  • the process for producing can provide an inj ection moulding, or co-moulding in particular of plastic and metallic materials . More precisely, the process can provide , in particular, a step for positioning the aforementioned main body 10 within a mould, block 304 , and, then, a step for inj ecting an elastic material , for example rubber, preferably melted, into the aforementioned main body 10 at the housing portion 11 . Then, a solidi fying step of the aforementioned elastic material within the housing portion 11 will produce a sealing portion 20 .
  • the solidi fying step produces the aforementioned firm anchoring of the housing portion 11 and the sealing portion 20 at the engagement surfaces 16 and 26 .
  • FIG 24 a possible layout is diagrammatically shown of a plant for producing the closing elements 1 for pharmaceutical containers according to the invention .
  • an apparatus 200 in particular provided with a push member 210 adapted to force a predetermined quantity of elastic material , preferably melted rubber, in particular melted butyl rubber, 155 , to pass through an inj ection mouth 215 , to be introduced within the mould 150 up to reaching a housing portion 11 of the main body 10 .
  • the material can be introduced already melted, in particular through an inlet duct , for example a hopper 220 , or can be introduced at the solid state, for example in granules and can be , then, melted by a heating system, not shown in figure for clarity reasons , of which the apparatus 200 can be provided with .
  • the elastic material will form the aforementioned sealing element 20 . More precisely, during the solidi fication of the elastic material 155 , a firm anchoring will be obtained of the sealing element 20 and the main body 10 , and precisely at the aforementioned housing portion 11 , at the aforementioned respective engagement surfaces 16 and 26 .
  • the aforementioned weakening line 18 can be made on the container body 10 before introducing the same within the mould 150, or at the end of the moulding, or comoulding, process, i.e. once that the sealing element 20 has been firmly anchored to the same.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Closing element (1) for a pharmaceutical container (50) provided with a cavity (55) delimited by a lateral wall (51) and with an aperture (52) laterally delimited by an edge (53). The closing element (1) comprises a main body (10) provided with a seal portion (15) configured to be engaged to the lateral wall (51) of the pharmaceutical container (50). The seal portion (15) is provided with a weakening line (18) delimiting a first part (15a) and a second part (15b). This latter is arranged to be removed disengaging from the first part (15a) at the weakening line (18). The closing element (1) comprises, furthermore, a housing portion (11) and a sealing portion (20) made of elastic material. This latter is housed, in use, within the housing portion (11) and is positioned in contact with the edge (53) of the aperture (52). The housing portion (11) and the sealing portion (20) are firmly anchored to each other at respective engagement surfaces (16,26). The weakening line (18) is positioned, in use, below the edge (53). The invention relates also to a process for producing the aforementioned sealing element (1) and to a system (100) for storing the pharmaceutical products.

Description

TITLE
CLOS ING ELEMENT FOR PHARMACEUTICAL CONTAINERS AND PROCESS FOR PRODUCING SUCH CLOS ING ELEMENT
DESCRIPTION
Field of the invention
The present invention relates to the pharmaceutical field and it relates , precisely, to a closing element , in particular a closure , or lid, or any other similar element for sealing a container such as a bottle , a vial , a small bottle , etc . that is intended to contain a pharmaceutical product .
Furthermore , the invention relates to a process for producing such a closing element for pharmaceutical containers .
Background of the invention
As known, many types of pharmaceutical containers exist that are used for containing pharmaceutical products in aseptic conditions . In particular, in order to be able to guarantee that the products contained within them are maintained in aseptic conditions , the containers as well as their closures have to be preliminarily sterili zed .
In order to be compliant with the law, once filled with the pharmaceutical product for which they are intended, the aforementioned pharmaceutical containers have to be hermetically sealed with closures that must be able to guarantee the integrity and the inviolability of their content until they are opened by the authori zed person . A very widespread type of closures for pharmaceutical containers comprises two distinct parts . More precisely, these closures provide a first part , normally a lid made of vulcani zed rubber, provided with a portion that , in working conditions , is housed within the container, and with another portion that , in use , is positioned in contact with the edge of the mouth of the pharmaceutical container . The closing element , furthermore , comprises a second part made of a metallic material , generally aluminium, which is superimposed to the aforementioned first part and fixed to the container, for example by crimping, in such a way that once removed it cannot be used anymore . More precisely, the second part of the closing element has , on the one hand, the aim to push the first part against the mouth of the pharmaceutical container in order to hermetically close the same and, on the other hand, it has the function of a seal , because it guarantees that it is not possible to reach the first part of the closing element without leaving any mark of the removal of the second part and, therefore , it guarantees the inviolability of the content of the pharmaceutical container .
However, the aforementioned type of closing members for pharmaceutical containers has many drawbacks .
Since , as described above , the containers for pharmaceutical use , as well as their closures , must be subj ected to processes for sterili zing the same , the aforementioned types of closure members which provide two members need to be subj ected to a process for sterili zing that is altogether long and complicated and that is , therefore , unavoidably highly expensive .
Furthermore , since the rubber, once vulcani zed cannot be recycled, the aforementioned type of closing members for pharmaceutical containers has a not-negligible environmental impact in particular due to the high quantity of vulcani zed rubber that is needed .
A further disadvantage of the closures for pharmaceutical containers formed by more components is that , at the moment to draw up the inventory, each component has to be registered separately with great loss of time and complications .
Some closures for pharmaceutical containers of known type are for example described in US3888377 , US2018 / 147115 and US2019/209435 .
The closures described in these documents are of the type that can be pierced by a needle to draw its content by a syringe . More in detail , the closures that are described in these documents are provided with a removable portion in order to expose , once removed, a portion made of rubber, or other material , suitable to be pierced by the needle . Therefore , these closures can be used only in the case that the pharmaceutical product contained within the pharmaceutical container is in liquid form and intended to be administered to the patient by inj ection .
Summary of the invention
It is , therefore , an obj ect of the present invention to provide a closing element for pharmaceutical containers that is able to overcome the drawbacks above disclosed of the closing members of prior art . It is , in particular, an obj ect of the present invention to provide a closing element for pharmaceutical containers that is able to simpli fy the processes for sterili zing the pharmaceutical containers and, therefore , to speed up the same in addition to reduce costs with respect to the closing members of prior art .
It is also an obj ect of the present invention to provide a closing element for pharmaceutical containers that is able to avoid that the pharmaceutical product which is contained in it , can be contaminated by extraneous substances until it is withdrawn from the pharmaceutical container .
It is another particular obj ect of the present invention to provide a closing element for pharmaceutical containers that is intended to store the pharmaceutical products in liquid, or solid, in particular powder, or gel , form .
It is another obj ect of the present invention to provide a closing element for pharmaceutical containers that is able to reduce the environmental impact with respect to analogous products of prior art .
It is an obj ect of the present invention to provide a process for producing such a closing element for pharmaceutical containers that is simple and cheap .
It is another obj ect of the invention to provide a system for storing a pharmaceutical product formed by a closing element according to the invention and a related pharmaceutical container having the same advantages indicated above .
These and other obj ects are obtained by a closing element for a pharmaceutical container provided with a cavity delimited by a lateral wall and with an aperture through which it is possible to reach said cavity, said aperture being laterally delimited by an edge , said closing element having a main body comprising :
- a seal portion configured to be engaged to said pharmaceutical container, said seal portion being provided with a weakening line delimiting a first part and a second part of said seal portion, said second part being arranged to be removed disengaging the same from said first part at said weakening line ;
- a housing portion made at said first part of said seal portion;
- a sealing portion made of elastic material and configured to be housed, in use , within said housing portion and to be positioned in contact with said edge of said aperture ; whose main characteristic is that the aforementioned housing portion and the aforementioned sealing portion are firmly anchored to each other at respective engagement surfaces , in such a way to be removed integrally with each other from the pharmaceutical container, that said seal portion is arranged to be engaged to said pharmaceutical container at said second part and that the weakening line is positioned, in use , below the aforementioned edge , in such a way that when said second part of said seal portion is removed, the sealing element is still covered by the first part of the seal portion .
Further technical characteristics of the invention and the related embodiments are set out in the dependent claims .
In particular, the aforementioned housing portion faces , in use , towards the aforementioned edge of the aforementioned aperture .
Preferably, the housing portion and the sealing portion can be firmly anchored to each other at the aforementioned engagement surface by an inj ection moulding process .
Alternatively, the housing portion and the sealing portion can be firmly anchored to each other at the aforementioned engagement surface by a process di comoulding, in particular co-moulding of metal and plastic materials .
In particular, the aforementioned main body can be made of a metallic material . More in particular, the main body can be made of aluminium . In this way, it is possible , in particular, to simpli fy the process for sterili zing the pharmaceutical container .
Preferably, the aforementioned sealing portion can be made of rubber .
Preferably, the aforementioned weakening line can be configured in such a way to disengage , in particular in an irreversible way, the aforementioned second part from the aforementioned first part of the seal portion when the second part is caused to rotate tangentially to the aforementioned first part .
Advantageously, the second part of the seal portion can be provided with a grasp portion configured to be grasped by a user in order to pull the second part same , in particular causing it to rotate tangentially to the aforementioned first part as above disclosed, in such a way to separate it from the first part .
In particular, the aforementioned sealing portion can be provided with at least one through hole adapted to be positioned, in use , above the aforementioned aperture of the pharmaceutical container . More in particular, the aforementioned sealing portion can have an annular shape .
Alternatively, the aforementioned sealing portion can be a substantially flat shaped element .
Advantageously, the sealing portion can have a circular, or elliptical , or polygonal , for example rectangular, or square, cross section .
According to another aspect of the invention, a process for producing a closing element for a pharmaceutical container provided with a cavity laterally delimited by a lateral wall and with an aperture through which it is possible to reach the aforementioned cavity, said aperture being laterally delimited by an edge , said process comprising the steps of :
- disposing of a main body provided with a seal portion configured to be engaged, in use , to said lateral wall of said pharmaceutical container and with a housing portion;
- making on said main body a weakening line delimiting a first and a second part of a seal portion adapted to be engaged, in use , to the aforementioned pharmaceutical container, in order to close the aforementioned aperture ;
- disposing of a sealing portion made of elastic material within said housing portion and positioned in contact with the aforementioned edge of the aperture ;
- anchoring said housing portion and said sealing portion to each other at respective engagement surfaces .
According to a further aspect of the invention, a process for producing a closing element for a pharmaceutical container provided with a cavity laterally delimited by a lateral wall and with an aperture through which it is possible to reach the aforementioned cavity, said aperture being laterally delimited by an edge , said process comprising the steps of :
- positioning a main body, in particular made of metallic material , within a mould, said main body being provided with :
- a seal portion configured to be engaged, in use , to said pharmaceutical container, said seal portion being provided with a weakening line delimiting a first part and a second part of said seal portion, said seal portion being arranged to be engaged to said pharmaceutical container at said second part , said second part being arranged to be removed disengaging form said first part at said weakening line , said weakening line being positioned, in use , below said edge of said pharmaceutical container ;
- a housing portion provided at said first part of said seal portion and adapted to face , in use , towards said edge of said aperture ;
- inj ecting a predetermined quantity of a melted elastic material into the aforementioned main body at a housing portion; - solidi fying the elastic material within the housing portion forming a sealing portion, during said solidi fying step said housing portion and said sealing portion being adapted to firmly anchor to each other at respective engagement surfaces .
According to still another aspect of the invention, a system for storing a product , in particular a pharmaceutical product, comprises :
- a pharmaceutical container provided with a cavity delimited by a lateral wall and with an aperture through which it is possible to reach said cavity, said aperture being laterally delimited by an edge ;
- a closing element as described above arranged to close said aperture of said pharmaceutical container .
Preferably, the pharmaceutical container, in particular made of metallic material , such as aluminium, or an aluminium alloy, can be provided with an end portion which protrudes from the aforementioned edge . More in particular, the aforementioned end portion can be configured to protrude from the aforementioned edge up to a free end .
More in detail , the aforementioned end portion can be shaped in such a way to bend towards the pharmaceutical container, in particular towards a portion having a reduced cross section, or neck, of the pharmaceutical container same . The free end of the end portion can be , in particular, positioned at a predetermined distance d from the lateral wall , in particular from the aforementioned portion having a reduced cross section, or neck of the pharmaceutical container . Advantageously, the aforementioned seal portion can be arranged to be engaged, in particular by crimping, to the pharmaceutical container at the aforementioned free end of the end portion .
In particular, the main body of the closing element and the pharmaceutical container can be made of the same material or, however, of two materials that can be sterili zed, in particular two metallic materials that can be sterili zed, for example aluminium, or an aluminium alloy .
Brief description of the drawings
The invention will be now illustrated with the following description of an exemplary embodiment thereof , exempli fying but not limitative , with reference to the attached drawings wherein :
Fig . l diagrammatically shows a side elevation perspective view of a pharmaceutical container provided with a closing element according to the invention in a disassembled configuration;
Fig . 2 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 1 in an assembled configuration;
Fig . 3 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element of figure 2 ;
Fig . 4 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 3 to highlight some technical aspects ; Fig . 5 diagrammatically shows a side elevation perspective view of a pharmaceutical container provided with an embodiment of the closing element alternative to that one of figure 2 ;
Fig . 6 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 5 during an initial stage of the removal step of the seal portion;
Fig . 7 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element of figure 6 ;
Fig . 8 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 7 to highlight some technical aspects ;
Fig . 9 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 5 at the end stage of the removal step of the seal portion;
Fig . 10 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element of figure 9 ;
Fig . 11 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 10 to highlight some technical aspects ;
Fig . 12 diagrammatically shows a side elevation perspective view of a pharmaceutical container provided with a further embodiment of the closing element alternative to that of figure 2 ;
Fig . 13 diagrammatically shows a side elevation perspective view of the pharmaceutical container and the closing element of figure 12 during an initial stage of the removal step of the seal portion;
Fig . 14 diagrammatically shows a longitudinal cross section view of the pharmaceutical container and the closing element di figure 12 ;
Fig . 15 diagrammatically shows a longitudinal cross section view of a pharmaceutical container provided with still another alternative embodiment of the closing element according to the invention;
Fig . 16 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 15 to highlight some technical aspects ;
Fig . 17 diagrammatically shows a perspective view of a possible alternative embodiment of the sealing element that can be used for the closing element according to the invention;
Fig . 18 diagrammatically shows a longitudinal cross section view of a possible embodiment alternative to that one of figure 16 of a pharmaceutical container to which the closing element according to the invention can be applied;
Fig . 19 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 18 to highlight some technical aspects ;
Fig . 20 diagrammatically shows a longitudinal cross section view of a possible embodiment alternative to that one of figure 19 of the closing element according to the invention;
Fig . 21 diagrammatically shows an enlargement of the pharmaceutical container and the closing element of figure 20 to highlight some technical aspects ;
Fig . 22 diagrammatically shows a block diagram of the main steps of the process , according to the invention, for producing the closing element for pharmaceutical containers ;
Fig . 23 diagrammatically shows a block diagram of the main steps of another process , according to the invention, for producing the closing element for pharmaceutical containers ;
Fig . 24 diagrammatically shows a possible layout of a plant for producing the closing element for pharmaceutical containers according to the invention .
Detailed description of some exemplary embodiments of the invention
As diagrammatically shown in figure 1 , a closing element 1 , according to the invention, for a pharmaceutical container 50 , such as a bottle , a vessel , a small bottle , a flask, provided with a cavity 55 delimited by a lateral wall 51 and an aperture 52 laterally delimited by an edge 53 , through which it is possible to reach the aforementioned cavity 55 . The closing element 1 comprises , in particular, a main body 10 comprising a seal portion 15 configured to be engaged to the lateral wall 51 of the pharmaceutical container 50 , for example by crimping . In particular, the aperture 52 of the aforementioned pharmaceutical container 50 can have a diameter equal to , or greater than 20 mm, for example comprised between 20 mm and 220 mm .
The closing element 1 comprises , furthermore , a housing portion 11 , in particular facing, in use , towards the aforementioned edge 53 of the aperture 52 , and a sealing portion 20 made of an elastic material and configured to be housed, in use , within the housing portion 11 . More in particular, the sealing portion 20 i s adapted to be positioned, in use , in contact with the edge 53 of the aperture 52 in such a way to tightly close the pharmaceutical container 50 .
According to the invention, the main body 10 and the aforementioned sealing portion 20 , which is housed within the housing portion 11 , are firmly anchored to each other at respective engagement surfaces 16 and 26 by an inj ection moulding, or co-moulding, process , in particular a co-moulding process of metal and plastic materials . In this way, at the moment of removing the closing element 1 from the closing position of the aperture 52 , the seal portion 15 and the sealing element 20 are removed integrally with each other . In particular, the main body 10 can be made of a metallic material , preferably aluminium, or an aluminium alloy .
Advantageously, the aforementioned sealing portion 20 can be made of rubber, preferably butyl rubber .
As diagrammatically shown, for example , in figure 19 , the seal portion 15 comprises a first part 15a and a second part 15b mutually engaged to each other in a removable way at an engagement portion 19 . More precisely, the seal portion 15 is engaged to the pharmaceutical container 50 , in particular to the neck of this , at the second part 15b . The seal portion 15 is provided with a weakening line 18 , in particular a portion having a reduced thickness , or a pre-cut line . The weakening line 18 delimits the first and the second part 15a and 15b, in the sense that it indicates the limit between the first and the second part 15a and 15b, of the seal portion 15 .
In particular, when a user grasps the second part 15b and pulls it , he/ she causes the same to be removed, i . e . its separation from the first part 15a at the weakening line 18 . Therefore , the closing element 1 is disengaged from the pharmaceutical container 50 and can be removed from the closing position of the aperture 52 when desired .
According to an embodiment , the weakening line 18 , and therefore the engagement portion 19 , can be configured in such a way to be broken disengaging the second part 15b of the seal portion 15 from the first part 15a, when a rotation of the second part 15b tangentially to the first part 15a is caused .
In a preferred embodiment , the weakening line 18 can be obtained by reducing locally the thickness of the seal portion 15 , whereby when the user grasps the second part 15b and applies a determined force on the same , it causes it to be separated from the first part 15a at the weakening line 18 .
In particular, the removal of the second part 15b, that means the breaking of the engagement portion 19 , can be obtained by rotating the second part 15b with respect to the first part 15a, in such a way to cause the two parts 15a and 15b of the seal portion 15 to be separated from each other . In particular, the technical solution provided by the present invention allows to avoid that , during the removal of the seal portion 15 , some particles of the material of which it is made of , can enter the pharmaceutical container 50 contaminating its content .
In particular, the seal portion 15 can be configured in such a way that once that the second part 15b is removed, the sealing element 20 is not exposed, and, therefore , it cannot be reached from the outside . This can be obtained, in particular, by positioning the weakening line 18 in a position such that when the second part 15b of the seal portion 15 is removed, the sealing element 20 remains covered, that means hidden, by the first part 15b, in particular entirely covered by the first part 15b .
This technical characteristic is an important novelty with respect to the prior art solutions where , instead, once that the removable part of the seal portion is removed, the sealing element is exposed to be perforated by a needle of a syringe in order to reach the pharmaceutical product contained within the pharmaceutical container and that , therefore , has to be necessarily in liquid form .
Preferably, the weakening line 18 can be made in such a way to be positioned, in use , below the edge 53 , or at least at the same height . In this way, at the moment to remove the second part 15b of the seal portion 15 , it is guaranteed that the sealing element 20 remains in a correct working position avoiding that extraneous bodies , in particular dust , dirty, which settles on the lateral wall 51 of the pharmaceutical container 50 , or on the seal portion 15 same , as well as other impurities , in particular metallic fragments of the material of which the pharmaceutical container 50 , and/or the closing element 1 , is made of , can enter the cavity 55 , contaminating its content .
In particular, as diagrammatically shown in the figures from 18 to 21 , the aforementioned pharmaceutical container 50 can be provided with an end portion 56 which protrudes from the edge 53 . More in particular, the aforementioned end portion 56 , starting from the aforementioned edge 53 from which it protrudes , bends towards the pharmaceutical container 50 , in such a way to be superimposed on a part of the lateral wall 51 of the pharmaceutical container 50 , in particular at least on a part of a portion having a reduced cross section, or neck 57 , of which the container same is provided of . More precisely, the end portion 56 protrudes from the edge 53 up to a free end 59 . Thi s is , preferably, positioned at a predetermined distance d from the lateral wall 51 of the pharmaceutical container, in particular the neck 57 of the same , i f present . In particular, the end portion 56 together with the pharmaceutical container 50 can delimit a cavity 58 .
In an embodiment of the invention, the weakening line 18 can be configured in such a way to be positioned, in use , at the end portion 56 , in particular between the edge 53 and the free end 59 of the end portion 56 .
In particular, the seal portion 15 , more precisely the second part 15b of this , can be engaged, for example by crimping, to the free end 59 of the end portion 56 , in such a way to ensure a firm anchoring of the seal portion 15 , and precisely of the second part 15b of this , to the pharmaceutical container 50 . As diagrammatically shown in the embodiments of the figures from 5 to 21 , the second part 15b of the seal portion 15 can be provided with a grasp portion 17 configured to be grasped by a user in order to cause the same to be rotated tangentially to the first part 15a, as disclosed above . For example, the grasp portion 17 can extend along a direction that is substantially radial to the main body 10 of the closing element 1 ( case that is shown in the figures from 5 to 11 ) or along a direction that is substantially tangential to the main body 10 (case that is shown as an example in the figures from 12 to 15 ) .
In particular, in working conditions , the sealing element 20 can extend between the opposite end portions 54a and 54b of the edge 53 of aperture 52 of the pharmaceutical container 50 and, therefore , be positioned upon the aperture 52 same for al l its length ( case that is shown, for example , in the figures 10 and 14 ) . For example , the sealing element 20 can have a substantially flat shape .
In an alternative embodiment that is diagrammatically shown in the figures from 15 to 21 , instead, the sealing element 20 can be provided with at least a hole 22 superimposed, in use , to the aperture 52 of the pharmaceutical container 50 . For example , the sealing element 20 can have an annular, or substantially annular, shape , in particular with a polygonal cross section, advantageously substantially square , or rectangular, or curved, in particular substantially elliptical , or circular, and can be placed on the edge 53 of the aperture 52 , but not upon this latter, or however, not upon the whole aperture 52 , leaving at least a part of the aperture 52 uncovered . Even though in the figures 15 and 16 , the sealing element is shown having a circular cross section, it is not excluded that it can have an elliptical , or polygonal , in particular square , or rectangular, cross section, cases that are not shown in the figure .
In particular, the main body 10 of the closing element 1 and the pharmaceutical container 50 are made of the same material , advantageously aluminium, or an aluminium alloy . In this way, it is possible to simpli fy the process for sterili zing both the closing element 1 and the pharmaceutical container 50 and to assure that , even i f the product passes through the hole 22 of the sealing element 20 and reaches the main body 10 of the closing element 1 , the necessary sterile conditions for the product that is contained in it are , anyway, maintained, thus avoiding any contamination of the same and, therefore , assuring the absolute integrity of the same .
According to another aspect of the invention, a pharmaceutical container 50 and a closing element 1 as described above with reference to the figures from 1 to 20 form a system 100 for storing a pharmaceutical product .
According to another aspect of the invention, a process for producing a closing element 1 for a pharmaceutical container 50 , such as a bottle , a small bottle , a test tube , but also a vial , and similar containers that are used in the pharmaceutical field, of the type described above with reference to the figures from 1 to 16 , and, in particular, provided with a cavity
55 laterally delimited by a lateral wall 51 and an aperture 52 through which it is possible to reach the aforementioned cavity 55 , can comprise the steps that are diagrammatically indicated in the block diagram 300 of figure 22 .
In particular, the process , according to the invention, provides a step of disposing of a main body 10 provided with a seal portion 15 configured to be engaged, in use , to the lateral wall 51 of the pharmaceutical container 50 and with a housing portion 11 , in particular adapted to face , in use , towards the edge 53 of the aperture 52 , block 301 .
Furthermore , a step is provided of positioning a sealing portion made of elastic material within the aforementioned housing portion 11 , block 302 , and therefore , a step for anchoring the housing portion 11 and the sealing portion 20 to each other at respective engagement surfaces 16 and 26 , block 303 .
In a preferred embodiment of the invention, the process for producing can provide an inj ection moulding, or co-moulding in particular of plastic and metallic materials . More precisely, the process can provide , in particular, a step for positioning the aforementioned main body 10 within a mould, block 304 , and, then, a step for inj ecting an elastic material , for example rubber, preferably melted, into the aforementioned main body 10 at the housing portion 11 . Then, a solidi fying step of the aforementioned elastic material within the housing portion 11 will produce a sealing portion 20 . More in particular, at the end of the aforementioned inj ection moulding, or co-moulding, process , the solidi fying step produces the aforementioned firm anchoring of the housing portion 11 and the sealing portion 20 at the engagement surfaces 16 and 26 .
In figure 24 a possible layout is diagrammatically shown of a plant for producing the closing elements 1 for pharmaceutical containers according to the invention . In particular, according to an embodiment of the invention, it is possible to obtain the closing element 1 positioning a main body 10 within a mould 150 and inj ecting by an apparatus 200 , in particular provided with a push member 210 adapted to force a predetermined quantity of elastic material , preferably melted rubber, in particular melted butyl rubber, 155 , to pass through an inj ection mouth 215 , to be introduced within the mould 150 up to reaching a housing portion 11 of the main body 10 . In particular, the material can be introduced already melted, in particular through an inlet duct , for example a hopper 220 , or can be introduced at the solid state, for example in granules and can be , then, melted by a heating system, not shown in figure for clarity reasons , of which the apparatus 200 can be provided with .
In this way, once and solidi fied, the elastic material will form the aforementioned sealing element 20 . More precisely, during the solidi fication of the elastic material 155 , a firm anchoring will be obtained of the sealing element 20 and the main body 10 , and precisely at the aforementioned housing portion 11 , at the aforementioned respective engagement surfaces 16 and 26 .
The aforementioned weakening line 18 can be made on the container body 10 before introducing the same within the mould 150, or at the end of the moulding, or comoulding, process, i.e. once that the sealing element 20 has been firmly anchored to the same.
The foregoing description of a specific embodiment will so fully reveal the invention according to the conceptual point of view, so that others, by applying current knowledge, will be able to modify and/or adapt for various applications such an embodiment without further research and without parting from the invention, and it is therefore to be understood that such adaptations and modifications will have to be considered as equivalent to the specific embodiment. The means and the materials to realise the different functions described herein could have a different nature without, for this reason, departing from the field of the invention. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation.

Claims

CLAIMS Closing element (1) for a pharmaceutical container (50) provided with a cavity (55) delimited by a lateral wall (51) and with an aperture (52) through which is possible to reach said cavity (55) , said aperture (52) being laterally delimited by an edge (53) , said closing element (1) having a main body (10) made of a metallic material and comprising:
- a seal portion (15) configured to be engaged to said pharmaceutical container (50) , said seal portion (15) being provided with a weakening line (18) delimiting a first part (15a) and a second part (15b) of said seal portion (15) , said second part (15b) being arranged to be removed disengaging from said first part (15a) at said weakening line (18) ;
- a housing portion (11) made at said first part (15a) of said seal portion (15) ;
- a sealing portion (20) made of an elastic material, said sealing portion (20) being arranged to be housed, in use, within said housing portion (11) and to be positioned in contact with said edge (53) of said aperture ( 52 ) ; said closing element (1) being characterized in that said housing portion (11) and said sealing portion (20) are firmly anchored to each other at respective engagement surfaces (16,26) , in such a way to be removed integrally with each other from said pharmaceutical container (50) , in that said seal portion (15) is arranged to be engaged to said pharmaceutical container (50) at said second part (15b) and in that said weakening line (18) is positioned, in use, below said edge (53) , in such a way that when said second part (15b) of said seal portion (15) is removed, said sealing element (20) remains covered by said first part (15a) of said seal portion ( 15) . Closing element (1) for a pharmaceutical container (50) according to claim 1, wherein said housing portion (11) and said sealing portion (20) are firmly anchored to each other at said respective engagement surfaces (16,26) by an injection moulding process. Closing element (1) for a pharmaceutical container (50) according to claim 1, wherein said housing portion (11) and said sealing portion (20) are firmly anchored to each other at said respective engagement surfaces (16,26) by a co-moulding process. Closing element (1) for a pharmaceutical container (50) according to any of the previous claims, wherein said sealing portion (20) is made of rubber. Closing element (1) for a pharmaceutical container (50) according to any of the previous claims, wherein said sealing portion (20) is provided with at least one hole (22) adapted to be, in use, positioned above said aperture (52) of said pharmaceutical container (50) . Closing element (1) for a pharmaceutical container (50) according to any of the previous claims, wherein said sealing portion (20) has an annular shape. Closing element (1) for a pharmaceutical container (50) according to any of the previous claims, wherein said main body (10) and said pharmaceutical container (50) are made of the same material. Closing element (1) for a pharmaceutical container (50) according to any of the previous claims, wherein said sealing portion (20) has a circular, or elliptical, or polygonal cross section. Closing element (1) for a pharmaceutical container (50) according to any of the previous claims, wherein said weakening line (18) is configured in such a way to disengage said second part (15b) from said first part (15a) when a rotation is caused of said second part (15b) tangentially to said first part (15a) . Closing element (1) for a pharmaceutical container (50) according to any of the previous claims, wherein said second part (15b) is provided with a grasp portion (17) configured to be grasped by a user to cause said second part (15b) to be removed. System (100) for storing a product, in particular a pharmaceutical product, characterized in that it comprises :
- a pharmaceutical container (50) provided with a cavity (55) delimited by a lateral wall (51) and an aperture (52) through which it is possible to reach said cavity (55) , said aperture (52) being laterally delimited by an edge (53) ;
- a closing element (1) according to any claim from 1 to 10 arranged to close said aperture (52) . System for storing a product, in particular a pharmaceutical product, according to claim 11, wherein said pharmaceutical container (50) is provided with an end portion (56) arranged to protrude from said edge (53) up to a free end (59) and to be shaped in such a way to be overlapped to said lateral wall (51) , said end portion (56) being configured in such a way that said free end (59) is positioned at a predetermined distance (d) from said lateral wall (51) . System for storing a product, in particular a pharmaceutical product, according to claim 12, wherein said seal portion (15) is arranged to be engaged by crimping to said end portion (56) at said free end (59) . System for storing a product, in particular a pharmaceutical product, according to any claim from 11 to 13, wherein said sealing element (20) is provided with a through hole (22) adapted to be positioned, in use, above said aperture (52) of said pharmaceutical container (50) . System for storing a product, in particular un pharmaceutical product, according to any claim from 11 to 14, wherein said main body (10) and said pharmaceutical container (50) are made of the same material . Process for producing a closing element (1) for a pharmaceutical container (50) provided with a cavity (55) laterally delimited by a lateral wall (51) and with an aperture (52) through which it is possible to reach said cavity (55) , said aperture (52) being laterally delimited by an edge (53) , said process comprising the steps of: positioning a main body (10) made of metallic material within a mould (150) , said main body (10) comprising a seal portion (15) configured to be engaged, in use, to said pharmaceutical container (50) and a housing portion (11) adapted to face, in use, towards said edge (53) of said aperture (52) , wherein said seal portion (15) is provided with a weakening line (18) delimiting a first part (15a) and a second part (15b) on said seal portion (15) , wherein said seal portion (15) is arranged to be engaged to said pharmaceutical container (50) at said second part (15b) , wherein said second part (15b) is arranged to be removed disengaging from said first part (15a) at said weakening line (18) , and wherein said weakening line (18) is positioned, in use, below said edge (53) of said pharmaceutical container (50) ;
- injecting a predetermined quantity of a melted elastic material into said main body (10) at a housing portion (11) ;
- solidifying said elastic material within said housing portion (11) forming a sealing portion (20) , during said solidifying step said housing portion (11) and said sealing portion (20) being adapted to be firmly anchored to each other at respective engagement surfaces (16,26) .
EP23707791.2A 2022-01-31 2023-01-31 Closing element for pharmaceutical containers and process for producing such closing element Pending EP4472600A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT202200001565 2022-01-31
PCT/IB2023/050821 WO2023144800A1 (en) 2022-01-31 2023-01-31 Closing element for pharmaceutical containers and process for producing such closing element

Publications (1)

Publication Number Publication Date
EP4472600A1 true EP4472600A1 (en) 2024-12-11

Family

ID=81327321

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23707791.2A Pending EP4472600A1 (en) 2022-01-31 2023-01-31 Closing element for pharmaceutical containers and process for producing such closing element

Country Status (2)

Country Link
EP (1) EP4472600A1 (en)
WO (1) WO2023144800A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888377A (en) * 1973-05-30 1975-06-10 Reinhard Stadler Closure cap for an infusion flask
US10159626B2 (en) * 2015-04-30 2018-12-25 Otsuka Pharmaceutical Factory, Inc. Lid cover for medicine container
PL3294256T3 (en) * 2015-05-13 2020-05-18 Fresenius Kabi Deutschland Gmbh Container for a medical liquid

Also Published As

Publication number Publication date
WO2023144800A1 (en) 2023-08-03

Similar Documents

Publication Publication Date Title
US4401227A (en) Tamper indicating closure cap
US5464111A (en) Closure for medication container
EP0569835B1 (en) Safety closing device for biological liquid containers
US4960206A (en) System for packaging a product and forewarning consumers if the package has been tampered with
US10994897B2 (en) Security closure system and devices for containers
EP1870347A2 (en) Stopper for flasks of sterile products and use of said stopper in sterile measured filling
RU2620979C2 (en) Method of container manufacture
JPS6350267B2 (en)
US4355729A (en) Single service childproof closure
EP4472600A1 (en) Closing element for pharmaceutical containers and process for producing such closing element
CA1190895A (en) Bottle opening ring having shock absorbing means
JPH04189755A (en) Cap structure
US6659296B2 (en) Cap for container
US5033712A (en) Container for fusible materials
US4056129A (en) Closable sterile container
US4384653A (en) Tip-off cap and closure for containers
JP3069036B2 (en) Pill fur proof cap
JP4898007B2 (en) Cap for container
US4403707A (en) Combination container cap and closure seal
JPH0721564U (en) Vial closure
US579619A (en) Stopper for bottles
JP4543693B2 (en) Cap with tamper-evident prevention and separation / collection function
US12187497B2 (en) Plastic closure device for a container for parenteral pharmaceutical products
EP1082152A1 (en) Pre-filled container
GB2232408A (en) Container closure

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240806

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20250908